Diabetes of Injury: Novel Insights

Endocrinology and Metabolism Clinics of North America

Volumn 35, Issue 4, 2006, Pages 859-872

  Vanhorebeek, Ilse ^a   Van den Berghe, Greet ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 2; GLUCOSE TRANSPORTER 3; GLUCOSE TRANSPORTER 4; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; REVIPARIN; TRIACYLGLYCEROL;

ACUTE HEART INFARCTION; ANEMIA; BLOOD GLUCOSE MONITORING; BRAIN INJURY; CLINICAL TRIAL; COMPUTER ASSISTED THERAPY; CRITICAL ILLNESS; DIABETES MELLITUS; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG EFFECT; ENDOCRINE FUNCTION; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE TRANSPORT; GLYCEMIC CONTROL; HOSPITAL INFECTION; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INFECTION; INFECTION PREVENTION; INSULIN TREATMENT; INTENSIVE CARE; INTENSIVE CARE UNIT; KIDNEY FAILURE; LIVER FUNCTION; LIVER MITOCHONDRION; LIVER PROTECTION; MULTIPLE ORGAN FAILURE; OSMOTIC STRESS; POLYNEUROPATHY; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; REVIEW; SEPSIS; SURGICAL PATIENT; SURVIVAL; SURVIVAL TIME;

CRITICAL ILLNESS; HUMANS; HYPERGLYCEMIA; INSULIN; INTENSIVE CARE;

EID: 33751205895     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ecl.2006.09.002     Document Type: Review

References (87)

1. Thorell A., Nygren J., and Ljungqvist O. Insulin resistance: a marker of surgical stress. Curr Opin Clin Nutr Metab Care 2 1 (1999) 69-78
2. McCowen K.C., Malhotra A., and Bistrian B.R. Stress-induced hyperglycaemia. Crit Care Clin 17 1 (2001) 107-124
3. Hill M., and McCallum R. Altered transcriptional regulation of phosphoenolpyruvate carboxykinase in rats following endotoxin treatment. J Clin Invest 88 3 (1991) 811-816
4. Khani S., and Tayek J.A. Cortisol increases gluconeogenesis in humans: its role in the metabolic syndrome. Clin Sci (Lond) 101 6 (2001) 739-747
5. Watt M.J., Howlett K.F., Febbraio M.A., et al. Adrenalin increases skeletal muscle glycogenolysis, pyruvate dehydrogenase activation and carbohydrate oxidation during moderate exercise in humans. J Physiol 534 Pt 1 (2001) 269-278
6. Flores E.A., Istfan N., Pomposelli J.J., et al. Effect of interleukin-1 and tumor necrosis factor/cachectin on glucose turnover in the rat. Metabolism 39 7 (1990) 738-743
7. Sakurai Y., Zhang X.J., and Wolfe R.R. TNF directly stimulates glucose uptake and leucine oxidation and inhibits FFA flux in conscious dogs. Am J Physiol 270 5 Pt 1 (1996) E864-E872
8. Lang C.H., Dobrescu C., and Bagby G.J. Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic glucose output. Endocrinology 130 1 (1992) 43-52
9. Wolfe R.R., Durkot M.J., Allsop J.R., et al. Glucose metabolism in severely burned patients. Metabolism 28 10 (1979) 1031-1039
10. Wolfe R.R., Herndon D.N., Jahoor F., et al. Effect of severe burn injury on substrate cycling by glucose and fatty acids. N Engl J Med 317 7 (1987) 403-408
11. Mizock B.A. Alterations in carbohydrate metabolism during stress: a review of the literature. Am J Med 98 1 (1995) 75-84
12. Boord J.B., Graber A.L., Christman J.W., et al. Practical management of diabetes in critically ill patients. Am J Respir Crit Care Med 164 10 Pt 1 (2001) 1763-1767
13. Pozzilli P., and Leslie R.D. Infections and diabetes: mechanisms and prospects for prevention. Diabet Med 11 10 (1994) 935-941
14. Yendamuri S., Fulda G.J., and Tinkoff G.H. Admission hyperglycemia as a prognostic indicator in trauma. J Trauma 55 1 (2003) 33-38
15. Laird A.M., Miller P.R., Kilgo P.D., et al. Relationship of early hyperglycemia to mortality in trauma patients. J Trauma 56 5 (2004) 1058-1062
16. Bochicchio G.V., Sung J., Joshi M., et al. Persistent hyperglycemia is predictive of outcome of critically ill trauma patients. J Trauma 58 5 (2005) 921-924
17. Sung J., Bochicchio G.V., Joshi M., et al. Admission hyperglycemia is predictive of outcome in critically ill trauma patients. J Trauma 59 1 (2005) 80-83
18. Rovlias A., and Kotsou S. The influence of hyperglycemia on neurological outcome in patients with severe head injury. Neurosurgery 46 2 (2000) 335-342
19. Jeremitsky E., Omert L.A., Dunham M., et al. The impact of hyperglycemia on patients with severe brain injury. J Trauma 58 1 (2005) 47-50
20. Capes S.E., Hunt D., Malmberg K., et al. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke 32 10 (2001) 2426-2432
21. Capes S.E., Hunt D., Malmberg K., et al. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 355 9206 (2000) 773-778
22. Muhlestein J.B., Anderson J.L., Horne B.D., et al. Effect of fasting glucose levels on mortality rate in patients with and without diabetes mellitus and coronary artery disease undergoing percutaneous coronary intervention. Am Heart J 146 2 (2003) 351-358
23. Bolton C.F. Sepsis and the systemic inflammatory response syndrome: neuromuscular manifestations. Crit Care Med 24 8 (1996) 1408-1416
24. Faustino E.V., and Apkon M. Persistent hyperglycemia in critically ill children. J Pediatr 146 1 (2005) 30-34
25. Krinsley J.S. Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin Proc 78 12 (2003) 1471-1478
26. Van den Berghe G., Wouters P., Weekers F., et al. Intensive insulin therapy in critically ill patients. N Engl J Med 345 19 (2001) 1359-1367
27. Ingels C, Debaveye Y, Milants I, et al. Strict blood glucose control with insulin during intensive care after cardiac surgery: impact on 4-years survival, dependency on medical care and quality of life. Eur Heart J, in press.
28. Van den Berghe G., Schoonheydt K., Becx P., et al. Insulin therapy protects the central and peripheral nervous system of intensive care patients. Neurology 64 8 (2005) 1348-1353
29. Van den Berghe G., Wouters P.J., Kesteloot K., et al. Analysis of healthcare resource utilization with intensive insulin therapy in critically ill patients. Crit Care Med 34 3 (2006) 612-616
30. Van den Berghe G., Wilmer A., Hermans G., et al. Intensive insulin therapy in medical intensive care patients. N Engl J Med 354 5 (2006) 449-461
31. Van den Berghe G, Wilmer A, Milants I, et al. Intensive insulin therapy in mixed medical/surgical ICU: benefit versus harm. Diabetes 2006;55(11):3151-9.
32. Krinsley J.S. Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc 79 8 (2004) 992-1000
33. Grey N.J., and Perdrizet G.A. Reduction of nosocomial infections in the surgical intensive-care unit by strict glycemic control. Endocr Pract 10 Suppl 2 (2004) 46-52
34. Van den Berghe G., Wouters P.J., Bouillon R., et al. Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control. Crit Care Med 31 2 (2003) 359-366
35. Finney S.J., Zekveld C., Elia A., et al. Glucose control and mortality in critically ill patients. JAMA 290 15 (2003) 2041-2047
36. Klip A., Tsakiridis T., Marette A., et al. Regulation of expression of glucose transporters by glucose: a review of studies in vivo and in cell cultures. FASEB J 8 1 (1994) 43-53
37. Pekala P., Marlow M., Heuvelman D., et al. Regulation of hexose transport in aortic endothelial cells by vascular permeability factor and tumor necrosis factor alfa, but not by insulin. J Biol Chem 265 30 (1990) 18051-18054
38. Shikhman A.R., Brinson D.C., Valbracht J., et al. Cytokine regulation of facilitated glucose transport in human articular chondrocytes. J Immunol 167 12 (2001) 7001-7008
39. Quinn L.A., and McCumbee W.D. Regulation of glucose transport by angiotensin II and glucose in cultured vascular smooth muscle cells. J Cell Physiol 177 1 (1998) 94-102
40. Clerici C., and Matthay M.A. Hypoxia regulates gene expression of alveolar epithelial transport proteins. J Appl Physiol 88 5 (2000) 1890-1896
41. Sanchez-Alvarez R., Tabernero A., and Medina J.M. Endothelin-1 stimulates the translocation and upregulation of both glucose transporter and hexokinase in astrocytes: relationship with gap junctional communication. J Neurochem 89 3 (2004) 703-714
42. Tirone T.A., and Brunicardi C. Overview of glucose regulation. World J Surg 25 4 (2001) 461-467
43. Vanhorebeek I., De Vos R., Mesotten D., et al. Strict blood glucose control with insulin in critically ill patients protects hepatocytic mitochondrial ultrastructure and function. Lancet 365 9453 (2005) 53-59
44. Brealey D., Brand M., Hargreaves I., et al. Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet 360 9328 (2002) 219-223
45. Brealey D., Karyampudi S., Jacques T.S., et al. Mitochondrial dysfunction in a long-term rodent model of sepsis and organ failure. Am J Physiol Regul Integr Comp Physiol 286 3 (2004) R491-R497
46. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 414 6865 (2001) 813-820
47. Aulak K.S., Koeck T., Crabb J.W., et al. Dynamics of protein nitration in cells and mitochondria. Am J Physiol Heart Circ Physiol 286 1 (2004) H30-H38
48. Frost M., Wang Q., Moncada S., et al. Hypoxia accelerates nitric oxide-dependent inhibition of mitochondrial complex I in activated macrophages. Am J Physiol Regul Integr Comp Physiol 288 2 (2005) R394-R400
49. Turina M., Fry D.E., and Polk Jr. H.C. Acute hyperglycemia and the innate immune system: clinical, cellular, and molecular aspects. Crit Care Med 33 7 (2005) 1624-1633
50. Rassias A.J., Marrin C.A., Arruda J., et al. Insulin infusion improves neutrophil function in diabetic cardiac surgery patients. Anesth Analg 88 5 (1999) 1011-1016
51. Nielson C.P., and Hindson D.A. Inhibition of polymorphonuclear leukocyte respiratory burst by elevated glucose concentrations in vitro. Diabetes 38 8 (1989) 1031-1035
52. Perner A., Nielsen S.E., and Rask-Madsen J. High glucose impairs superoxide production from isolated blood neutrophils. Intensive Care Med 29 4 (2003) 642-645
53. Rayfield E.J., Ault M.J., Keusch G.T., et al. Infection and diabetes: the case for glucose control. Am J Med 72 3 (1982) 439-450
54. Furnary A.P., Zerr K.J., Grunkemeier G.L., et al. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg 67 2 (1999) 352-360
55. Weekers F., Van Herck E., Coopmans W., et al. A novel in vivo rabbit model of hypercatabolic critical illness reveals a bi-phasic neuroendocrine stress response. Endocrinology 143 3 (2002) 764-774
56. Weekers F., Giuletti A.-P., Michalaki M., et al. Endocrine and immune effects of stress hyperglycemia in a rabbit model of prolonged critical illness. Endocrinology 144 12 (2003) 5329-5338
57. Mesotten D., Swinnen J.V., Vanderhoydonc F., et al. Contribution of circulating lipids to the improved outcome of critical illness by glycemic control with intensive insulin therapy. J Clin Endocrinol Metab 89 1 (2004) 219-226
58. Mesotten D., Delhanty P.J., Vanderhoydonc F., et al. Regulation of insulin-like growth factor binding protein-1 during protracted critical illness. J Clin Endocrinol Metab 87 12 (2002) 5516-5523
59. Ellger B., Debaveye Y., Vanhorebeek I., et al. Survival benefits of intensive insulin therapy in critical illness. Impact of normoglycemia versus glycemia-independent actions of insulin. Diabetes 55 4 (2006) 1096-1105
60. Lanza-Jacoby S., Wong S.H., Tabares A., et al. Disturbances in the composition of plasma lipoproteins during gram-negative sepsis in the rat. Biochim Biophys Acta 1124 3 (1992) 233-240
61. Khovidhunkit W., Memon R.A., Feingold K.R., et al. Infection and inflammation-induced proatherogenic changes of lipoproteins. J Infect Dis 181 Suppl 3 (2000) S462-S472
62. Carpentier Y.A., and Scruel O. Changes in the concentration and composition of plasma lipoproteins during the acute phase response. Curr Opin Clin Nutr Metab Care 5 2 (2002) 153-158
63. Jeschke M.G., Klein D., and Herndon D.N. Insulin treatment improves the systemic inflammatory reaction to severe trauma. Ann Surg 239 4 (2004) 553-560
64. Tulenko T.N., and Sumner A.E. The physiology of lipoproteins. J Nucl Cardiol 9 6 (2002) 638-649
65. Harris H.W., Grunfeld C., Feingold K.R., et al. Human very low density lipoproteins and chylomicrons can protect against endotoxin-induced death in mice. J Clin Invest 86 3 (1990) 696-702
66. Harris H.W., Grunfeld C., Feingold K.R., et al. Chylomicrons alter the fate of endotoxin, decreasing tumor necrosis factor release and preventing death. J Clin Invest 91 3 (1993) 1028-1034
67. Vanhorebeek I., and Van den Berghe G. Hormonal and metabolic strategies to attenuate catabolism in critically ill patients. Curr Opin Pharmacol 4 6 (2004) 621-628
68. Vanhorebeek I., Langouche L., and Van den Berghe G. Endocrine aspects of acute and prolonged critical illness. Nature Clin Pract Endocrinol Metab 2 1 (2006) 20-31
69. Gore D.C., Wolf S.E., Sanford A.P., et al. Extremity hyperinsulinemia stimulates muscle protein synthesis in severely injured patients. Am J Physiol Endocrinol Metab 286 4 (2004) E529-E534
70. Agus M.S.D., Javid P.J., Ryan D.P., et al. Intravenous insulin decreases protein breakdown in infants on extracorporeal membrane oxygenation. J Pediatr Surg 39 6 (2004) 839-844
71. Zhang X.J., Chinkes D.L., Irtun O., et al. Anabolic action of insulin on skin wound protein is augmented by exogenous amino acids. Am J Physiol Endocrinol Metab 282 6 (2002) E1308-E1315
72. Mesotten D., Wouters P.J., Peeters R.P., et al. Regulation of the somatotropic axis by intensive insulin therapy during protracted critical illness. J Clin Endocrinol Metab 89 7 (2004) 3105-3113
73. Hansen T.K., Thiel S., Wouters P.J., et al. Intensive insulin therapy exerts anti-inflammatory effects in critically ill patients, as indicated by circulating mannose-binding lectin and C-reactive protein levels. J Clin Endocrinol Metab 88 3 (2003) 1082-1088
74. Langouche L., Vanhorebeek I., Vlasselaers D., et al. Intensive insulin therapy protects the endothelium of critically ill patients. J Clin Invest 115 8 (2005) 2277-2286
75. Jeschke M.G., Klein D., Bolder U., et al. Insulin attenuates the systemic inflammatory response in endotoxemic rats. Endocrinology 145 9 (2004) 4084-4093
76. Brix-Christensen V., Andersen S.K., Andersen R., et al. Acute hyperinsulinemia restrains endotoxin-induced systemic inflammatory response: an experimental study in a porcine model. Anesthesiology 100 4 (2004) 861-870
77. Klein D., Schubert T., Horch R.E., et al. Insulin treatment improves hepatic morphology and function through modulation of hepatic signals after severe trauma. Ann Surg 240 2 (2004) 340-349
78. Das U.N. Insulin: an endogenous cardioprotector. Curr Opin Crit Care 9 5 (2003) 375-383
79. Jonassen A., Aasum E., Riemersma R., et al. Glucose-insulin-potassium reduces infarct size when administered during reperfusion. Cardiovasc Drugs Ther 14 6 (2000) 615-623
80. Gao F., Gao E., Yue T., et al. Nitric oxide mediates the antiapoptotic effect of insulin in myocardial ischemia-reperfusion: the role of PI3-kinase, Akt and eNOS phosphorylation. Circulation 105 12 (2002) 1497-1502
81. Jonassen A., Sack M., Mjos O., et al. Myocardial protection by insulin at reperfusion requires early administration and is mediated via Akt and p70s6 kinase cell-survival signalling. Circ Res 89 12 (2001) 1191-1198
82. The CREATE-ECLA Trial Group Investigators. Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction. The CREATE-ECLA randomized controlled trial. JAMA 293 4 (2005) 437-446
83. Malmberg K., Ryden L., Wedel H., et al. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI-2): effects on mortality and morbidity. Eur Heart J 26 7 (2005) 650-661
84. Van den Berghe G. How does blood glucose control with insulin save lives in intensive care?. J Clin Invest 114 9 (2004) 1187-1195
85. Siroen M.P.C., van Leeuwen P.A.M., Nijveldt R.J., et al. Modulation of asymmetric dimethylarginine in critically ill patients receiving intensive insulin treatment: a possible explanation of reduced morbidity and mortality?. Crit Care Med 33 3 (2005) 504-510
86. Nijveldt R.J., Teerlink T., and van Leeuwen P.A. The asymmetric dimethylarginine (ADMA)-multiple organ failure hypothesis. Clin Nutr 22 1 (2003) 99-104
87. Vanhorebeek I., Peeters R.P., Vander Perre S., et al. Cortisol response to critical illness: effect of intensive insulin therapy. J Clin Endocrinol Metab 91 10 (2006) 3803-3813